1. Home
  2. NICE vs ALKS Comparison

NICE vs ALKS Comparison

Compare NICE & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$119.24

Market Cap

6.4B

Sector

Technology

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$28.40

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICE
ALKS
Founded
1986
1987
Country
Israel
Ireland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.5B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
NICE
ALKS
Price
$119.24
$28.40
Analyst Decision
Buy
Buy
Analyst Count
13
14
Target Price
$158.85
$43.43
AVG Volume (30 Days)
739.9K
1.8M
Earning Date
02-19-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.43
Revenue
N/A
$1,475,899,000.00
Revenue This Year
$10.21
$24.06
Revenue Next Year
$9.70
$4.53
P/E Ratio
$11.21
$19.08
Revenue Growth
N/A
N/A
52 Week Low
$94.65
$25.17
52 Week High
$180.61
$36.32

Technical Indicators

Market Signals
Indicator
NICE
ALKS
Relative Strength Index (RSI) 53.31 39.48
Support Level $104.02 $27.48
Resistance Level $136.93 $28.75
Average True Range (ATR) 4.11 0.92
MACD -0.61 -0.06
Stochastic Oscillator 25.18 37.46

Price Performance

Historical Comparison
NICE
ALKS

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: